Why the study?
What is the safety and efficacy of chronic captopril therapy in patients with clinical hypertension?
Population
81 patients with different types of clinical hypertension, mostly previously uncontrollable high blood…
Design
Cohort
Follow-up
2 years
Authors
Loading...
Captopril adverse effects were frequent in hypertension and increased with renal impairment; supports renal dose adjustment but leaves optimal regimens open to prospective trials.
What is the safety and efficacy of chronic captopril therapy in patients with clinical hypertension?
Early clinical experience with captopril for severe hypertension revealed a high rate of adverse effects (46.9%), suggesting the need for lower, renally-adjusted dosing.
Waeber et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: